$ 47.99Add to cart
Ovagen is a complex peptide, comprising amino acids contributing to liver function normalization and gastrointestinal tract.
Liver - life support laboratory of the human body. Prevention and treatment of liver diseases and lesions are extremely important task in restoring and maintaining health. Liver infection, viral, drug, alcohol, toxic nature eventually lead to acute or chronic liver failure. These factors have a negative effect on the antitoxic, excretory and protein-synthetic function of the liver. To correct these pathological changes in the liver developed hepatic bioregulator - Ovagen with a protective and regenerating action on liver cells.
In a clinical study established efficacy Ovagen in comprehensive prevention and treatment of patients suffering from hepatitis of various etiologies, in the prevention of complications of radiation and chemotherapy and the side effects of the use of antibiotics and other drugs, as well as the impacts on the body of various unfavorable factors (including environmental, toxic), and malnutrition, as well as for maintaining liver function in people with middle and old age.
After treatment with Ovagen most patients with chronic persistent hepatitis and chronic liver failure, noted weakness elimination, improved appetite and increased efficiency, reduction of dyspeptic disorders, reducing the intensity of pain.
Ovagen: clinical trials
Experimental study of the biological properties of OVAGEN in animals has shown that when it is used not only improves individual cellular and tissue homeostasis in liver cells, but also to normalize the function of the digestive system as a whole, disturbed as a result of stress, negative effects of adverse environmental factors, age pathology . Currently, there is an increase in the number of patients with chronic liver disease, which are distributed mainly in people of working age. A large role in increasing the incidence of adverse belongs to social and environmental factors.
In a clinical study OVAGEN attended 106 patients with chronic hepatitis and cancer patients after a course of chemotherapy, including 60 men and 46 women aged from 35 to 68 years. Disease duration ranged from 3 to 10 years. Patients of the main group (68 people) in addition to conventional treatment facilities OVAGEN received 2 capsules 2 times daily with meals for 20 days. The control group consisted of 38 similar patients who were appointed only conventional medicines.
Most of the patients complained of pain in the right hypochondrium, general weakness and fatigue, 73% of patients had diarrhea disorders. In 53% of patients registered hyperbilirubinemia, increased alanine aminotransferase, increased globulin fraction of the blood proteins, mainly due to the fraction of immunoglobulin M, which indicates a certain activity of chronic inflammation.
Subjective complaints of patients evaluated in dynamics. Performed clinical blood and urine tests, biochemical and immunological blood test (determination of immunoglobulins according to Mancini), ultrasound of the liver.
After applying OVAGEN majority of patients noted weakness elimination, improved appetite and efficiency. In 53% of patients significantly reduced the intensity of pain.
In cancer patients noted subjective improvement of health, reduction of weakness, reducing the intensity of dyspeptic disorders.
Particular attention in the analysis of the effectiveness of OVAGEN on assessing biochemical studies characterizing aminotransferase activity, pigment and protein function of the liver. Objectively, the majority of patients after application OVAGEN observed stabilization of biochemical parameters: bilirubin, alanine aminotransferase. The study of peripheral blood immunoglobulins, which are an essential criterion for the activity of the inflammatory process, after a course of application OVAGEN showed a significant decrease in the level of IgM.
Thus, the results of a clinical study demonstrate hepatoprotective properties OVAGEN and appropriateness of its use in patients with acute ihronicheskimi forms of liver disease, cancer patients after radiation and chemotherapy, as well as for the prevention of various liver diseases and their complications.
During the clinical study OVAGEN revealed no side effects, complications, and drug addiction.
Ovagen well tolerated, with no side effects were detected, complications, contraindications and drug dependence.
Adults take 1-2 capsules 1-2 times a day with meals. Duration of 10-30 days. It is advisable to repeat the course in 4-6 months.
Important notice - the outer box design may vary before prior notice!